In Regard to Mignot et  al

We read the article “Solitary plasmacytoma: Lenalidomide-dexamethasone combined with radiation therapy improves progression-free survival and multiple myeloma-free survival” with great interest.1 It offers a combined treatment for solitary plasmacytoma (SP), which has a significant risk of progression to multiple m yeloma (MM). The diagnosis of SP and elimination of MM should include biopsies from the primary lesion and bone marrow (BM), multiparameter flow cytometry, serum and urine electrophoresis, immunoglobulins (Ig), Free Light Chain assay, Bence-Jones proteins, and skeletal survey with magnetic resonance imaging or positron emission tomography-computed tomography.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Comment Source Type: research